Hazlett, Burt & Watson
CLBT icon

Hazlett, Burt & Watson’s Cellebrite CLBT Stock Holding History

Hazlett, Burt & Watson’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$11K Hold
1,000
– – ﹤0.01% 679
2026
Q2 		$15K Hold
1,000
– – ﹤0.01% 637
2026
Q1 		$14K Hold
1,000
– – ﹤0.01% 640
2025
Q4 		$18K Hold
1,000
– – 0.01% 609
2025
Q3 		$19K Buy
+1,000
New +$15.7K 0.01% 567

Other funds holding CLBT

True Wind Capital Management
True Wind Capital Management San Francisco, California $156M AUM 31.3% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Central Securities
Central Securities New York $1.39B AUM 16.6% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Brown Capital Management
Brown Capital Management Baltimore, Maryland $527M AUM 33.67% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.3B AUM 19.37% 1-Year Est. Return
Pembroke Management
Pembroke Management Montreal, Quebec, Canada $809M AUM 17.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Hazlett, Burt & Watson's CLBT Position: Q3 2026 in Review

Hazlett, Burt & Watson held its Cellebrite (CLBT) position steady in Q3 2026 at 1,000 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #679.

Hazlett, Burt & Watson first reported a position in CLBT in Q3 2025 and has held it in 5 quarters since. The position peaked at $19K in Q3 2025. 57 funds tracked by Wall St. Rank hold CLBT as of Q3 2026.

  • Hazlett, Burt & Watson held 1,000 shares of Cellebrite worth $11K as of Q3 2026.
  • Hazlett, Burt & Watson left its Cellebrite share count unchanged in Q3 2026.
  • Cellebrite made up ﹤0.01% of Hazlett, Burt & Watson's portfolio in Q3 2026, its #679 holding.
  • Hazlett, Burt & Watson first reported a position in Cellebrite in Q3 2025 and has held it in 5 quarters since.
  • Hazlett, Burt & Watson's Cellebrite position peaked at $19K in Q3 2025.
  • 57 funds tracked by Wall St. Rank held Cellebrite as of Q3 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q3 2026, filed 4 Nov 2026.